Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A XNAS: KNSA

Strong Performer, Getting Expensive

Download real time

40.29 -0.29 (-0.71%)

Near 52W High of $42.05

264.6K

XNAS Volume

XNAS 13 Nov, 2025 4:30 PM (EST)

Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents